Lab Notes: Verrica throws support behind FDA crackdown; Janssen drug targeted for Medicare price negotiations


This week's pharmaceuticals and life sciences industry news includes items on a Chester County pharma firm's skin disease medicine, a local drug that made it on the federal government's initial Medicare drug price negotiation list, and more.

Previous 2023 NextGen BHM in Money: Genesis Howard, The Piedmont Group
Next Dr. Michael Bain, TriHealth's first chief medical informatics officer, announces exit